Skip to main content
. 2020 Mar 12;11(4):491–496. doi: 10.1021/acsmedchemlett.9b00612

Table 2. % Activity Remaining and IC50 Values of Nilotinib, Ponatinib, 4, and 5 for Selected Kinases.

  % Activity Remaining
% Activity Remaining and [IC50 (μM)]
kinase Nilotinib Ponatinib 4 5
ABL 2 1 8 [0.0031] 11 [0.0013]
DDR2 4 3 70 [>20] 14 [0.2862]
PDGFRa 56 25 10 [0.0021] 16 [0.0020]
Src 74 11 23 [0.7097] 15 [0.4313]
EPHB2 25 2 2 [0.0932] 1 [0.0708]
EPHB3 52 1 6 [0.0505] 5 [0.0195]
Lck 37 29 22 [0.0908] 17 [0.0261]
EPHA4 23 4 6 [0.1381] 2 [0.0846]
NEK6 97 52 45 [3.3060] 9 [5.3500]
VEGFR 75 28 14 [0.0336] 13 [0.0448]
MAP4K3 107 2 62 [>20] 14 [0.2404]